Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction, United States
Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction
• Estimated nirsevimab coverage for children 0-19 months is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group.
• Starting in July 2023, the CDC recommended the RSV vaccine to protect against serious illness from RSV. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)
Resources
3 resources available
-
Resource 1
TEXT/CSV -
Resource 2
APPLICATION/JSON -
Resource 3
APPLICATION/XML
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[ "009:20" ] |
| contactPoint |
{ "fn": "VaxView Team", "@type": "vcard:Contact", "hasEmail": "mailto:VaxView@cdc.gov" } |
| description | Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction • Estimated nirsevimab coverage for children 0-19 months is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group. • Starting in July 2023, the CDC recommended the RSV vaccine to protect against serious illness from RSV. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html) |
| distribution |
[ { "@type": "dcat:Distribution", "mediaType": "text/csv", "downloadURL": "https://data.cdc.gov/api/v3/views/ku7p-zn4c/export.csv?accessType=DOWNLOAD" }, { "@type": "dcat:Distribution", "mediaType": "application/json", "downloadURL": "https://data.cdc.gov/api/v3/views/ku7p-zn4c/query.json?accessType=DOWNLOAD" }, { "@type": "dcat:Distribution", "mediaType": "application/xml", "downloadURL": "https://data.cdc.gov/api/v3/views/ku7p-zn4c/query.xml?accessType=DOWNLOAD" } ] |
| identifier | https://data.cdc.gov/api/views/ku7p-zn4c |
| issued | 2024-02-13 |
| keyword |
[ "iis", "immunization information system", "rsv vaccination" ] |
| landingPage | https://www.cdc.gov/vaccines/vaxview/index.html |
| language |
[ "English" ] |
| license | https://www.usa.gov/government-works |
| modified | 2026-08-03 |
| programCode |
[ "009:020" ] |
| publisher |
{ "name": "Centers for Disease Control and Prevention", "@type": "org:Organization" } |
| spatial | Jurisdictions - States, District of Columbia, Islands, and US cities |
| theme |
[ "Vaccinations" ] |
| title | Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction, United States |
